Dr. Markus Bitzer, MD
Claim this profileStudies Diabetic Kidney Disease
Studies Type 2 Diabetes
1 reported clinical trial
1 drug studied
Clinical Trials Markus Bitzer, MD is currently running
More about Markus Bitzer, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Markus Bitzer, MD has experience with
- Canagliflozin
Breakdown of trials Markus Bitzer, MD has run
Diabetic Kidney Disease
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Markus Bitzer, MD specialize in?
Markus Bitzer, MD focuses on Diabetic Kidney Disease and Type 2 Diabetes. In particular, much of their work with Diabetic Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Markus Bitzer, MD currently recruiting for clinical trials?
Yes, Markus Bitzer, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Markus Bitzer, MD has studied deeply?
Yes, Markus Bitzer, MD has studied treatments such as Canagliflozin.
What is the best way to schedule an appointment with Markus Bitzer, MD?
Apply for one of the trials that Markus Bitzer, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.